
What is Zepbound and who is it for?
Zepbound (tirzepatide) is a prescription medicine made by Eli Lilly. Used with a reduced-calorie diet and more physical activity, it is FDA-approved to:
Help you lose weight and keep it off: in adults with obesity, or adults with overweight and at least one weight-related condition.
Treat obstructive sleep apnea: moderate to severe obstructive sleep apnea in adults with obesity.
Mounjaro also contains tirzepatide. It is approved for type 2 diabetes, not for weight loss. Read about Mounjaro.

What results looked like in the main trial
In SURMOUNT-1, a 72-week trial of 2,539 adults with obesity, or overweight and a weight-related condition, who did not have diabetes, people taking tirzepatide lost an average of 15.0% of their body weight on 5 mg a week, 19.5% on 10 mg and 20.9% on 15 mg. People taking a placebo lost 3.1%.
Half or more of the people on 10 mg (50%) and 15 mg (57%) lost 20% or more of their body weight, compared with 3% on placebo. The most common side effects were stomach-related, mostly mild to moderate, and happened mainly while the dose was being raised.
Your results will be your own. A trial average is not a promise, and what you build alongside the medicine, protein, strength work and sleep, helps decide whether the weight stays off.
Source: Jastreboff AM and colleagues, New England Journal of Medicine, 2022 (SURMOUNT-1).

How Zepbound works
Tirzepatide acts like two hormones your gut releases after you eat, GIP and GLP-1. Together they work on the biology that pushes back when you try to lose weight.
Quiets hunger: it signals your brain that you have had enough, so smaller portions feel like enough.
Keeps you full longer: food leaves your stomach more slowly, so you stay satisfied between meals.
Steadies blood sugar: it helps your body release insulin when blood sugar rises.
Taking it safely
Zepbound is a once-weekly injection under the skin of your stomach area, thigh or upper arm, at any time of day, with or without food. It comes as a pen or a vial. Your physician starts you on 2.5 mg and raises the dose in steps, and your care team shows you how to inject.
Most side effects are stomach-related and ease as your body adjusts. Zepbound is not right for everyone, so your physician goes through your health history with you first. The details from the FDA label are below.
Dosing steps
- The label starts at 2.5 mg once a week for 4 weeks. That dose is only for getting started.
- Then 5 mg a week. After at least 4 weeks on a dose, your physician may raise it by 2.5 mg.
- For weight, the maintenance dose is 5 mg, 10 mg or 15 mg a week. For sleep apnea, it is 10 mg or 15 mg.
- The highest dose is 15 mg a week.
Common side effects
- The most common side effects are stomach-related: nausea, diarrhea, vomiting, constipation, stomach pain and indigestion. Reactions where you inject, tiredness, burping, reflux and hair loss can also happen.
- They are most likely when you start or raise the dose, and they often ease as your body adjusts.
- Your care team can help with what to eat, portion size and dose timing while your body gets used to it.
Boxed warning
- In studies in rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid cancer, in people.
- Tell your physician right away about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Who should not take it
- Tirzepatide is not for you if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).
- It is also not for anyone who has had a serious allergic reaction to tirzepatide or to anything in the medicine.
- Do not take it with another tirzepatide or GLP-1 medicine.
- If you are pregnant or planning a pregnancy, tell your physician.
Less common but serious
- Less common but serious problems listed on the label include severe stomach problems, kidney problems from losing fluid through vomiting or diarrhea, gallbladder problems and inflammation of the pancreas.
- Others are serious allergic reactions, low blood sugar (mostly with insulin or a sulfonylurea) and eye changes in people with type 2 diabetes.
- If you take birth control pills, the Zepbound label advises switching to a non-oral method, or adding a barrier method, for 4 weeks after you start and for 4 weeks after each dose increase.
- Tell your care team before any surgery or sedation: GLP-1 medicines can raise the risk of food getting into the lungs during anesthesia.
What Zepbound costs
With insurance: coverage depends on your plan. We check it before your first visit, submit the prior authorization for you and handle appeals if needed. Read how to check your GLP-1 coverage.
Copay help: we help you use the maker's copay assistance if you have commercial insurance.
Paying cash: as of November 2026, Zepbound vials on LillyDirect are $299 (2.5 mg), $399 (5 mg), and $449 (7.5 mg to 15 mg with a refill within 45 days; $499 for 7.5 mg and $699 for 10 to 15 mg otherwise), per 4 vials (28 days). TrumpRx lists Zepbound from $299 a month. You pay the maker's pharmacy, not Aayu Well, and the maker may change its prices. You can compare cash prices.
Medicare: we bill Medicare for visits, and we prescribe through the Medicare GLP-1 Bridge for people who qualify: $50 a month, July 1, 2026 to December 31, 2027. Read how the Medicare GLP-1 Bridge works.
Your visits: Most major insurance accepted, plus convenient cash pay options. Visits are billed to your insurance, and you pay any copay.
Coverage rules are changing. Read what changes for coverage in 2027.
How Aayu Well helps
Insurance checked first: we look at your coverage before your first visit, so you know your options before you decide.
Prior authorization handled: our team prepares and submits it for brand-name medicine as a concierge service, and handles appeals if your plan says no. Read how a Zepbound appeal works.
Copay help: if you have commercial insurance, we help you use the maker's copay assistance.
A physician who knows you: Darshan Patel, MD, an obesity medicine physician, sees you by video or in person in Deer Park, Illinois, and adjusts your dose with you.
A registered dietitian: help with meals that fit your new appetite, protein on a GLP-1 and keeping your muscle.
A care team between visits: message us about side effects, doses or refills, and hear back from people who know your plan.
A plan for the long run: Do I have to take a GLP-1 forever?
We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin.














